EN HU

Tóth Gábor

Name: Tóth Gábor
Other profiles: MTMT
Degree:
  • PhD, Debreceni Egyetem (2018)

Publication list

Uploaded publications:
12
Publications in DEA:
12
OA:
10
Date range:
2013-2024
2024
1.
Katona, T., Tóth, G., Petró, M., Harangi, B.: Advanced Multi-Label Image Classification Techniques Using Ensemble Methods.
Mach. Learn. Knowl. Extr. 6 (2), 1281-1297, 2024.
Journal metrics:
Q1 Artificial Intelligence
D1 Engineering (miscellaneous)
2.
Hevessy, Z., Tóth, G., Antal-Szalmás, P., Tőkés-Füzesi, M., Kappelmayer, J., Kárai, B., Ajzner, É., Working Group on Guidelines, Algorithms of the Hungarian Society of Laboratory Medicine: Algorithm of differential diagnosis of anemia involving laboratory medicine specialists to advance diagnostic excellence.
Clin. Chem. Lab. Med. 62 (3), 410-420, 2024.
Journal metrics:
Q1 Biochemistry (medical)
Q2 Clinical Biochemistry
Q1 Medicine (miscellaneous)
3.
Katona, T., Tóth, G., Petró, M., Harangi, B.: Developing New Fully Connected Layers for Convolutional Neural Networks with Hyperparameter Optimization for Improved Multi-Label Image Classification.
Mathematics. 12 (6), 1-16, (article identifier: 806), 2024.
Journal metrics:
Q2 Computer Science (miscellaneous)
Q2 Engineering (miscellaneous)
Q2 Mathematics (miscellaneous)
4.
Németh, Á., Tóth, G., Fülöp, P., Paragh, G., Nádró, B., Karányi, Z., Paragh, G. J., Horváth, Z., Csernák, Z., Pintér, E., Sándor, D., Bagyó, G., Édes, I., Kappelmayer, J., Harangi, M., Daróczy, B.: Smart Medical Report SMR: efficient detection of common and rare diseases on common blood tests.
Front. Digit. Health. 6, 1-17, (article identifier: 1505483), 2024.
Journal metrics:
Q1 Biomedical Engineering
Q1 Computer Science Applications
Q1 Health Informatics
Q1 Medicine (miscellaneous)
2023
5.
Sebestyén, E., Major, N., Bodoki, L., Makai, A., Balogh, I., Tóth, G., Orosz, Z., Árkosy, P., Vaskó, A., Hódosi, K., Szekanecz, Z., Szekanecz, É., Hungarian OncoRheumatology Network (HORN) initiative: Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience.
Front Oncol. 13, 1-9, (article identifier: 1252215), 2023.
Journal metrics:
Q2 Cancer Research
Q2 Oncology
6.
Fazekas, L., Szabó, B., Szegeczki, V., Fillér, C., Varga, Á., Godó, Z., Tóth, G., Reglődi, D., Juhász, T., Németh, N.: Impact Assessment of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Hemostatic Sponge on Vascular Anastomosis Regeneration in Rats.
Int. J. Mol. Sci. 24, 1-24, (article identifier: 16695), 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2020
7.
Tóth, G., Szöllősi, J., Abken, H., Vereb, G., Szöőr, Á.: A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
Int. J. Mol. Sci. 21 (3), 1-11, 2020.
Journal metrics:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
8.
Szöőr, Á., Tóth, G., Zsebik, B., Szabó, V., Eshhar, Z., Abken, H., Vereb, G.: Trastuzumab Derived HER2-specific CARs for the Treatment of Trastuzumab-Resistant Breast Cancer: CAR T Cells Penetrate and Eradicate Tumors That Are Not Accessible to Antibodies.
Cancer Lett. 484, 1-8, 2020.
Journal metrics:
Q1 Cancer Research
Q1 Oncology
2017
9.
Tóth, G., Szöllősi, J., Vereb, G.: Quantitating ADCC against adherent cells: impedance-based detection is superior to release, membrane permeability, or caspase activation assays in resolving antibody dose response.
Cytom. Part A. 91 (10), 1021-1029, 2017.
Journal metrics:
Q2 Cell Biology
Q1 Histology
Q1 Pathology and Forensic Medicine
2016
10.
Szöőr, Á., Ujlaky-Nagy, L., Tóth, G., Szöllősi, J., Vereb, G.: Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms.
Cell. Signal. 28 (2), 81-93, 2016.
Journal metrics:
Q2 Cell Biology
11.
Tóth, G., Szöőr, Á., Simon, L., Yarden, Y., Szöllősi, J., Vereb, G.: The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity.
mAbs. 8 (7), 1361-1370, 2016.
Journal metrics:
Q2 Immunology
Q1 Immunology and Allergy
2013
12.
Roszik, J., Tóth, G., Szöllősi, J., Vereb, G.: Validating pharmacological disruption of protein-protein interactions by acceptor photobleaching FRET imaging.
In: Target Identification and Validation in Drug Discovery. Eds.: Jürgen Moll, Riccardo Colombo, Humana Press, Totowa, NJ, 165-78, 2013. ISBN: 9781627033107
DEENK University of Debrecen
© 2012 University of Debrecen